Ryan P - Search Results

1

Characterizing database granularity using SNOMED-CT hierarchy.

Ostropolets A, Reich C, Ryan P, Weng C, Molinaro A, DeFalco F, Jonnagaddala J, Liaw ST, Jeon H, Park RW, Spotnitz ME, Natarajan K, Argyriou G, Kostka K, Miller R, Williams A, Minty E, Posada J, Hripcsak G. Ostropolets A, et al. Among authors: ryan p. AMIA Annu Symp Proc. 2021 Jan 25;2020:983-992. eCollection 2020. AMIA Annu Symp Proc. 2021. PMID: 33936474 Free PMC article.

2

Evaluation of alternative standardized terminologies for medical conditions within a network of observational healthcare databases.

Reich C, Ryan PB, Stang PE, Rocca M. Reich C, et al. J Biomed Inform. 2012 Aug;45(4):689-96. doi: 10.1016/j.jbi.2012.05.002. Epub 2012 Jun 7. J Biomed Inform. 2012. PMID: 22683994 Free article.

3

Applying standardized drug terminologies to observational healthcare databases: a case study on opioid exposure.

Defalco FJ, Ryan PB, Soledad Cepeda M. Defalco FJ, et al. Health Serv Outcomes Res Methodol. 2013 Mar;13(1):58-67. doi: 10.1007/s10742-012-0102-1. Epub 2012 Oct 27. Health Serv Outcomes Res Methodol. 2013. PMID: 23396660 Free PMC article.

4

A comparison of the empirical performance of methods for a risk identification system.

Ryan PB, Stang PE, Overhage JM, Suchard MA, Hartzema AG, DuMouchel W, Reich CG, Schuemie MJ, Madigan D. Ryan PB, et al. Drug Saf. 2013 Oct;36 Suppl 1:S143-58. doi: 10.1007/s40264-013-0108-9. Drug Saf. 2013. PMID: 24166231

5

Alternative outcome definitions and their effect on the performance of methods for observational outcome studies.

Reich CG, Ryan PB, Schuemie MJ. Reich CG, et al. Drug Saf. 2013 Oct;36 Suppl 1:S181-93. doi: 10.1007/s40264-013-0111-1. Drug Saf. 2013. PMID: 24166234

6

The impact of drug and outcome prevalence on the feasibility and performance of analytical methods for a risk identification and analysis system.

Reich CG, Ryan PB, Suchard MA. Reich CG, et al. Drug Saf. 2013 Oct;36 Suppl 1:S195-204. doi: 10.1007/s40264-013-0112-0. Drug Saf. 2013. PMID: 24166235

7

Medication-wide association studies.

Ryan PB, Madigan D, Stang PE, Schuemie MJ, Hripcsak G. Ryan PB, et al. CPT Pharmacometrics Syst Pharmacol. 2013 Sep 18;2(9):e76. doi: 10.1038/psp.2013.52. CPT Pharmacometrics Syst Pharmacol. 2013. PMID: 24448022 Free PMC article.

8

A distribution-based method for assessing the differences between clinical trial target populations and patient populations in electronic health records.

Weng C, Li Y, Ryan P, Zhang Y, Liu F, Gao J, Bigger JT, Hripcsak G. Weng C, et al. Among authors: ryan p. Appl Clin Inform. 2014 May 7;5(2):463-79. doi: 10.4338/ACI-2013-12-RA-0105. eCollection 2014. Appl Clin Inform. 2014. PMID: 25024761 Free PMC article.

9

Fidelity assessment of a clinical practice research datalink conversion to the OMOP common data model.

Matcho A, Ryan P, Fife D, Reich C. Matcho A, et al. Among authors: ryan p. Drug Saf. 2014 Nov;37(11):945-59. doi: 10.1007/s40264-014-0214-3. Drug Saf. 2014. PMID: 25187016 Free PMC article.

10

Similarity-based modeling applied to signal detection in pharmacovigilance.

Vilar S, Ryan PB, Madigan D, Stang PE, Schuemie MJ, Friedman C, Tatonetti NP, Hripcsak G. Vilar S, et al. Among authors: ryan pb. CPT Pharmacometrics Syst Pharmacol. 2014 Sep 24;3(9):e137. doi: 10.1038/psp.2014.35. CPT Pharmacometrics Syst Pharmacol. 2014. PMID: 25250527 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,487 results

Search Page